S100PBP has been reported to inhibit the adhesion of pancreatic cancer cells through the S100PBP/CTSZ/RGD αvβ5 pathway (Lines et al, 2012; Lu et al, 2021) and plays a tumor suppressor role (Srivastava et al, 2023). Here, S100PBP is linked to neoplasm.